[1] |
WALDECKER CB, ZGOURA P, SEIBERT FS, et al. Biopsy findings after detection of de novo donor-specific antibodies in renal transplant recipients: a single center experience[J]. J Nephrol, 2021, 34(6): 2017-2026. DOI: 10.1007/s40620-021-01040-y.
|
[2] |
LIU W, ZHAO J, KANG ZY, et al. De novo donor-specific HLA antibodies reduce graft survival rates and increase the risk of kidney transplant rejection: a single-center retrospective study[J]. Transpl Immunol, 2021, 68: 101430. DOI: 10.1016/j.trim.2021.101430.
|
[3] |
DHARNIDHARKA VR, FIORINA P, HARMON WE. Kidney transplantation in children[J]. N Engl J Med, 2014, 371(6): 549-558. DOI: 10.1056/NEJMra1314376.
|
[4] |
EVERLY MJ, BRILEY KP, HAISCH CE, et al. Racial differences in incident de novo donor-specific anti-HLA antibody among primary renal allograft recipients: results from a single center cohort study[J]. Transpl Int, 2017, 30(6): 566-578. DOI: 10.1111/tri.12937.
|
[5] |
EVERLY MJ, REBELLATO LM, HAISCH CE, et al. Incidence and impact of de novo donor-specific alloantibody in primary renal allografts[J]. Transplantation, 2013, 95(3): 410-417. DOI: 10.1097/TP.0b013e31827d62e3.
|
[6] |
DEMIROK A, RANZIJN C, LARDY J, et al. Evaluation of the current post-transplantation human leukocyte antigen antibody screening in pediatric renal transplant recipients[J]. Pediatr Transplant, 2019, 23(2): e13338. DOI: 10.1111/petr.13338.
|
[7] |
SHARMA A, TAVERNITI A, GRAF N, et al. The association between human leukocyte antigen eplet mismatches, de novo donor-specific antibodies, and the risk of acute rejection in pediatric kidney transplant recipients[J]. Pediatr Nephrol, 2020, 35(6): 1061-1068. DOI: 10.1007/s00467-020-04474-x.
|
[8] |
CIONI M, NOCERA A, INNOCENTE A, et al. De novo donor-specific HLA antibodies developing early or late after transplant are associated with the same risk of graft damage and loss in nonsensitized kidney recipients[J]. J Immunol Res, 2017: 1747030. DOI: 10.1155/2017/1747030.
|
[9] |
GINEVRI F, NOCERA A, COMOLI P, et al. Posttransplant de novo donor-specific HLA antibodies identify pediatric kidney recipients at risk for late antibody-mediated rejection[J]. Am J Transplant, 2012, 12(12): 3355-3362. DOI: 10.1111/j.1600-6143.2012.04251.x.
|
[10] |
CHARNAYA O, TUCHMAN S, MOUDGIL A. Results of early treatment for de novo donor-specific antibodies in pediatric kidney transplant recipients in a cross-sectional and longitudinal cohort[J]. Pediatr Transplant, 2018, 22(2): e13108. DOI: 10.1111/petr.13108.
|
[11] |
FERNANDEZ HE. Application and interpretation of histocompatibility data in pediatric kidney transplantation[J]. Curr Opin Organ Transplant, 2017, 22(4): 426-432. DOI: 10.1097/MOT.0000000000000425.
|
[12] |
FILIPPONE EJ, FARBER JL. The problem of subclinical antibody-mediated rejection in kidney transplantation[J]. Transplantation, 2021, 105(6): 1176-1187. DOI: 10.1097/TP.0000000000003543.
|
[13] |
VELIDEDEOGLU E, CAVAILLÉ-COLL MW, BALA S, et al. Summary of 2017 FDA Public Workshop: antibody-mediated rejection in kidney transplantation[J]. Transplantation, 2018, 102(6): e257-e264. DOI: 10.1097/TP.0000000000002141.
|
[14] |
VO AA, AUBERT O, HAAS M, et al. Clinical relevance of posttransplant DSAs in patients receiving desensitization for HLA-incompatible kidney transplantation[J]. Transplantation, 2019, 103(12): 2666-2674. DOI: 10.1097/TP.0000000000002691.
|
[15] |
KONVALINKA A, TINCKAM K. Utility of HLA antibody testing in kidney transplantation[J]. J Am Soc Nephrol, 2015, 26(7): 1489-1502. DOI: 10.1681/ASN.2014080837.
|
[16] |
TAFULO S, MALHEIRO J, SANTOS S, et al. HLA class Ⅱ eplet mismatch load improves prediction of dnDSA development after living donor kidney transplantation[J]. Int J Immunogenet, 2021, 48(1): 1-7. DOI: 10.1111/iji.12519.
|
[17] |
AHLENSTIEL-GRUNOW T, PAPE L. Diagnostics, treatment, and immune response in BK polyomavirus infection after pediatric kidney transplantation[J]. Pediatr Nephrol, 2020, 35(3): 375-382. DOI: 10.1007/s00467-018-4164-3.
|
[18] |
TANNÉ C, ROY P, FROBERT É, et al. Cytomegalovirus infection in the first year after pediatric kidney transplantation[J]. Nephrol Ther, 2019, 15(1): 44-50. DOI: 10.1016/j.nephro.2018.04.003.
|
[19] |
TSAMPALIEROS A, KNOLL GA, MOLNAR AO, et al. Corticosteroid use and growth after pediatric solid organ transplantation: a systematic review and Meta-analysis[J]. Transplantation, 2017, 101(4): 694-703. DOI: 10.1097/TP.0000000000001320.
|
[20] |
STROMMEN AM, MOSS MC, GOEBEL J, et al. Donor-specific antibodies in a pediatric kidney transplant population-prevalence and association with antiproliferative drug dosing[J]. Pediatr Transplant, 2019, 23(6): e13511. DOI: 10.1111/petr.13511.
|
[21] |
HOEGY D, BLEYZAC N, ROBINSON P, et al. Medication adherence in pediatric transplantation and assessment methods: a systematic review[J]. Patient Prefer Adherence, 2019, 13: 705-719. DOI: 10.2147/PPA.S200209.
|
[22] |
GAJARDO M, DELUCCHI A, PÉREZ D, et al. Long-term outcome of early steroid withdrawal in pediatric renal transplantation[J]. Pediatr Transplant, 2021, 25(8): e14096. DOI: 10.1111/petr.14096.
|
[23] |
SHEN Q, FANG X, MAN X, et al. Pediatric kidney transplantation in China: an analysis from the IPNA Global Kidney Replacement Therapy Registry[J]. Pediatr Nephrol, 2021, 36(3): 685-692. DOI: 10.1007/s00467-020-04745-7.
|
[24] |
LIU L, ZHANG H, FU Q, et al. Current status of pediatric kidney transplantation in China: data analysis of Chinese Scientific Registry of Kidney Transplantation[J]. Chin Med J (Engl), 2014, 127(3): 506-510.
|
[25] |
陈刚. 中国儿童肾移植的现状及对未来发展的思考[J]. 中华器官移植杂志, 2020, 41(1): 1-2. DOI: 10.3760/cma.j.issn.0254-1785.2020.01.001.CHEN G. Current situation of renal transplantation in children in China and its future development[J]. Chin J Organ Transplant, 2020, 41(1): 1-2. DOI: 10.3760/cma.j.issn.0254-1785.2020.01.001.
|
[26] |
CHARNAYA O, JONES J, PHILOGENE MC, et al. Eplet mismatches associated with de novo donor-specific HLA antibody in pediatric kidney transplant recipients[J]. Pediatr Nephrol, 2020, 36(12): 3971-3979. DOI: 10.1007/s00467-021-05078-9.
|
[27] |
SYPEK MP, HIHO S, CANTWELL L, et al. Human leukocyte antigen eplet mismatches and long-term clinical outcomes in pediatric renal transplantation: a pragmatic, registry-based study[J]. Pediatr Transplant, 2020, 24(4): e13705. DOI: 10.1111/petr.13705.
|
[28] |
KAUSMAN JY, WALKER AM, CANTWELL LS, et al. Application of an epitope-based allocation system in pediatric kidney transplantation[J]. Pediatr Transplant, 2016, 20(7): 931-938. DOI: 10.1111/petr.12815.
|
[29] |
LARKINS NG, WONG G, TAVERNITI A, et al. Epitope matching in kidney transplantation: recent advances and current limitations[J]. Curr Opin Organ Transplant, 2019, 24(4): 370-377. DOI: 10.1097/MOT.0000000000000657.
|
[30] |
CHANDAR J, CHEN L, DEFREITAS M, et al. Donor considerations in pediatric kidney transplantation[J]. Pediatr Nephrol, 2021, 36(2): 245-257. DOI: 10.1007/s00467-019-04362-z.
|